Dianthus Therapeutics Statistics
Total Valuation
DNTH has a market cap or net worth of $671.29 million. The enterprise value is $363.36 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
DNTH has 32.19 million shares outstanding. The number of shares has increased by 71.34% in one year.
Current Share Class | 32.19M |
Shares Outstanding | 32.19M |
Shares Change (YoY) | +71.34% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 0.20% |
Owned by Institutions (%) | 62.11% |
Float | 11.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 151.71 |
Forward PS | 275.58 |
PB Ratio | 2.21 |
P/TBV Ratio | 2.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 74.86 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.12, with a Debt / Equity ratio of 0.00.
Current Ratio | 13.12 |
Quick Ratio | 12.81 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.71% and return on invested capital (ROIC) is -24.49%.
Return on Equity (ROE) | -34.71% |
Return on Assets (ROA) | -23.37% |
Return on Invested Capital (ROIC) | -24.49% |
Return on Capital Employed (ROCE) | -42.46% |
Revenue Per Employee | $62,231 |
Profits Per Employee | -$1.47M |
Employee Count | 78 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.21% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -21.21% |
50-Day Moving Average | 19.40 |
200-Day Moving Average | 21.43 |
Relative Strength Index (RSI) | 54.53 |
Average Volume (20 Days) | 338,690 |
Short Selling Information
The latest short interest is 6.40 million, so 19.88% of the outstanding shares have been sold short.
Short Interest | 6.40M |
Short Previous Month | 6.10M |
Short % of Shares Out | 19.88% |
Short % of Float | 58.08% |
Short Ratio (days to cover) | 17.49 |
Income Statement
In the last 12 months, DNTH had revenue of $4.85 million and -$114.75 million in losses. Loss per share was -$3.25.
Revenue | 4.85M |
Gross Profit | 4.85M |
Operating Income | -129.92M |
Pretax Income | -56.68M |
Net Income | -114.75M |
EBITDA | -129.81M |
EBIT | -129.92M |
Loss Per Share | -$3.25 |
Full Income Statement Balance Sheet
The company has $257.39 million in cash and $1.33 million in debt, giving a net cash position of $307.76 million or $9.56 per share.
Cash & Cash Equivalents | 257.39M |
Total Debt | 1.33M |
Net Cash | 307.76M |
Net Cash Per Share | $9.56 |
Equity (Book Value) | 303.08M |
Book Value Per Share | 9.42 |
Working Capital | 243.51M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$100.23 million and capital expenditures -$126,000, giving a free cash flow of -$100.36 million.
Operating Cash Flow | -100.23M |
Capital Expenditures | -126,000 |
Free Cash Flow | -100.36M |
FCF Per Share | -$3.12 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -2,676.56% |
Pretax Margin | -2,364.11% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DNTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -71.34% |
Shareholder Yield | -71.34% |
Earnings Yield | -17.10% |
FCF Yield | -14.95% |
Analyst Forecast
The average price target for DNTH is $53.00, which is 154.14% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $53.00 |
Price Target Difference | 154.14% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 99.37% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
DNTH has an Altman Z-Score of 17.18 and a Piotroski F-Score of 1.
Altman Z-Score | 17.18 |
Piotroski F-Score | 1 |